Concepedia

Shaokun Shu

SS

Statistics

Publications

26

Citations

2.3K

H-Index

21

Active since

2004

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Peking University Cancer Hospital

Peking University

Brigham and Women's Hospital

Shaokun Shu is an author at Dana-Farber Cancer Institute specializing in oncology, molecular oncology, and life sciences.

ORCID

Publications per year

2004–2025

26

Publications

26

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

Shaokun Shu, Charles Y. Lin, Housheng Hansen He et al. · Nature · 2016 · 629 citations · Full text

, , +14

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer

Shaokun Shu, Hua‐Jun Wu, Jennifer Y. Ge et al. · Molecular Cell · 2020 · 207 citations · Full text

, , +17

Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments

Michalina Janiszewska, Doris P. Tabassum, Zafira Castaño et al. · Nature Cell Biology · 2019 · 162 citations · Full text

, , +14

Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes

Andriy Marusyk, Doris P. Tabassum, Michalina Janiszewska et al. · Cancer Research · 2016 · 140 citations · Full text

, , +17

Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery

Lu‐Hai Wang, George Z. Cheng, Sungman Park et al. · Current Cancer Drug Targets · 2008 · 116 citations

, , +17

1–5 of 26